Legal & General Group Plc - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$2,161,262
-1.0%
138,9850.0%0.00%0.0%
Q2 2023$2,182,760
-4.7%
138,9850.0%0.00%0.0%
Q1 2023$2,289,780
+5.6%
138,9850.0%0.00%0.0%
Q4 2022$2,168,862
+20.4%
138,9850.0%0.00%0.0%
Q3 2022$1,802,000
-7.6%
138,9850.0%0.00%0.0%
Q2 2022$1,951,000
-2.0%
138,9850.0%0.00%0.0%
Q1 2022$1,991,000
+5.1%
138,9850.0%0.00%0.0%
Q4 2021$1,894,000
-16.8%
138,9850.0%0.00%0.0%
Q3 2021$2,277,000
-2.6%
138,9850.0%0.00%0.0%
Q2 2021$2,338,000
-7.9%
138,9850.0%0.00%0.0%
Q1 2021$2,539,000
+0.4%
138,9850.0%0.00%0.0%
Q4 2020$2,529,000
+2.0%
138,9850.0%0.00%0.0%
Q3 2020$2,480,000
-0.4%
138,9850.0%0.00%0.0%
Q2 2020$2,491,000
+18.1%
138,9850.0%0.00%0.0%
Q1 2020$2,109,000
-32.7%
138,985
-12.5%
0.00%0.0%
Q4 2019$3,134,000
+3.7%
158,784
-9.6%
0.00%
-50.0%
Q3 2019$3,022,000
-2.8%
175,6340.0%0.00%0.0%
Q2 2019$3,108,000
-59.8%
175,634
-53.6%
0.00%
-50.0%
Q1 2019$7,731,000378,5240.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders